Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
Condition:   Non-Seminomatous Germ Cell Tumor Interventions:   Drug: BEP Protocol;   Drug: Dose-dense regimen;   Procedure: Early tumor resection or HD-CT Sponsor:   Gustave Roussy, Cancer Campus, Grand Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials